• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道菌群失调与血流动力学变化作为肝硬化并发症发病机制的关联

Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis.

作者信息

Efremova Irina, Maslennikov Roman, Poluektova Elena, Zharkova Maria, Kudryavtseva Anna, Krasnov George, Fedorova Maria, Shirokova Elena, Kozlov Evgenii, Levshina Anna, Ivashkin Vladimir

机构信息

Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, 119991 Moscow, Russia.

The Interregional Public Organization "Scientific Community for the Promotion of the Clinical Study of the Human Microbiome", 119991 Moscow, Russia.

出版信息

Microorganisms. 2023 Aug 31;11(9):2202. doi: 10.3390/microorganisms11092202.

DOI:10.3390/microorganisms11092202
PMID:37764046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10537778/
Abstract

The aim was to evaluate the relationship between gut dysbiosis and hemodynamic changes (hyperdynamic circulation) in cirrhosis, and between hemodynamic changes and complications of this disease. This study included 47 patients with cirrhosis. Stool microbiome was assessed using 16S rRNA gene sequencing. Echocardiography with a simultaneous assessment of blood pressure and heart rate was performed to assess systemic hemodynamics. Patients with hyperdynamic circulation had more severe cirrhosis, lower albumin, sodium and prothrombin levels, higher C-reactive protein, aspartate aminotransferase and total bilirubin levels, and higher incidences of portopulmonary hypertension, ascites, overt hepatic encephalopathy, hypoalbuminemia, hypoprothrombinemia, systemic inflammation, and severe hyperbilirubinemia than patients with normodynamic circulation. Patients with hyperdynamic circulation compared with those with normodynamic circulation had increased abundance of Proteobacteria, Enterobacteriaceae, Bacilli, Streptococcaceae, Lactobacillaceae, Fusobacteria, Micrococcaceae, Intestinobacter, Clostridium sensu stricto, Proteus and Rumicoccus, and decreased abundance of Bacteroidetes, Bacteroidaceae, Holdemanella, and Butyrivibrio. The systemic vascular resistance and cardiac output values correlated with the abundance of Proteobacteria, Enterobacteriaceae, Bacilli, Streptococcaceae, Lactobacillaceae, Micrococcaceae, and Fusobacteria. Heart rate and cardiac output value were negatively correlated with the abundance of Bacteroidetes. The mean pulmonary artery pressure value was positively correlated with the abundance of Proteobacteria and Micrococcaceae, and negatively with the abundance of Holdemanella.

摘要

本研究旨在评估肝硬化患者肠道菌群失调与血流动力学变化(高动力循环)之间的关系,以及血流动力学变化与该疾病并发症之间的关系。本研究纳入了47例肝硬化患者。采用16S rRNA基因测序评估粪便微生物群。进行超声心动图检查并同时评估血压和心率,以评估全身血流动力学。与血流动力学正常的患者相比,高动力循环患者的肝硬化更严重,白蛋白、钠和凝血酶原水平更低,C反应蛋白、天冬氨酸转氨酶和总胆红素水平更高,门肺高压、腹水、显性肝性脑病、低白蛋白血症、低凝血酶原血症、全身炎症和严重高胆红素血症的发生率更高。与血流动力学正常的患者相比,高动力循环患者的变形菌门、肠杆菌科、芽孢杆菌属、链球菌科、乳杆菌科、梭杆菌属、微球菌科、肠道杆菌属、严格意义上的梭菌属、变形杆菌属和瘤胃球菌属丰度增加,而拟杆菌门、拟杆菌科、霍尔德曼菌属和丁酸弧菌属丰度降低。全身血管阻力和心输出量值与变形菌门、肠杆菌科、芽孢杆菌属、链球菌科、乳杆菌科、微球菌科和梭杆菌属的丰度相关。心率和心输出量值与拟杆菌门的丰度呈负相关。平均肺动脉压值与变形菌门和微球菌科的丰度呈正相关,与霍尔德曼菌属的丰度呈负相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edeb/10537778/5bc01be394b6/microorganisms-11-02202-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edeb/10537778/9b2de9e406d6/microorganisms-11-02202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edeb/10537778/b9fb5c134b57/microorganisms-11-02202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edeb/10537778/1c68e53e7c69/microorganisms-11-02202-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edeb/10537778/602dc5649240/microorganisms-11-02202-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edeb/10537778/5bc01be394b6/microorganisms-11-02202-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edeb/10537778/9b2de9e406d6/microorganisms-11-02202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edeb/10537778/b9fb5c134b57/microorganisms-11-02202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edeb/10537778/1c68e53e7c69/microorganisms-11-02202-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edeb/10537778/602dc5649240/microorganisms-11-02202-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edeb/10537778/5bc01be394b6/microorganisms-11-02202-g005.jpg

相似文献

1
Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis.肠道菌群失调与血流动力学变化作为肝硬化并发症发病机制的关联
Microorganisms. 2023 Aug 31;11(9):2202. doi: 10.3390/microorganisms11092202.
2
Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis.肠道菌群失调和小肠细菌过度生长作为肝硬化中肠道微生物群紊乱的独立形式。
World J Gastroenterol. 2022 Mar 14;28(10):1067-1077. doi: 10.3748/wjg.v28.i10.1067.
3
Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis.肝硬化中肠道微生物群和血管内皮功能障碍的生物标志物。
Int J Mol Sci. 2024 Feb 6;25(4):1988. doi: 10.3390/ijms25041988.
4
Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis.肠道菌群失调与肝硬化患者较差的长期预后相关。
World J Hepatol. 2021 May 27;13(5):557-570. doi: 10.4254/wjh.v13.i5.557.
5
Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial.益生菌对肝硬化相关血流动力学变化及并发症的影响:一项初步随机对照试验。
World J Hepatol. 2022 Aug 27;14(8):1667-1677. doi: 10.4254/wjh.v14.i8.1667.
6
Gut dysbiosis and body composition in cirrhosis.肝硬化中的肠道菌群失调与身体组成
World J Hepatol. 2022 Jun 27;14(6):1210-1225. doi: 10.4254/wjh.v14.i6.1210.
7
Gut Microbiota and Cytokine Profile in Cirrhosis.肝硬化中的肠道微生物群与细胞因子谱
J Clin Transl Hepatol. 2024 Aug 28;12(8):689-700. doi: 10.14218/JCTH.2024.00090. Epub 2024 Jun 28.
8
Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?肝硬化中的肠-肝轴:血流动力学变化是缺失的环节吗?
World J Clin Cases. 2021 Nov 6;9(31):9320-9332. doi: 10.12998/wjcc.v9.i31.9320.
9
Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis.肠道微生物群的改变与辅助益生菌治疗肝硬化的疗效。
Front Cell Infect Microbiol. 2023 Jul 7;13:1218552. doi: 10.3389/fcimb.2023.1218552. eCollection 2023.
10
Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis.可溶性髓系细胞触发受体-1作为细菌移位的生物标志物及肝硬化患者益生菌使用指征
World J Hepatol. 2024 May 27;16(5):822-831. doi: 10.4254/wjh.v16.i5.822.

引用本文的文献

1
Gut microbiota analysis in cirrhosis and non-cirrhotic portal hypertension suggests that portal hypertension can be main factor of cirrhosis-specific dysbiosis.肝硬化和非肝硬化门静脉高压症的肠道微生物群分析表明,门静脉高压可能是肝硬化特异性生态失调的主要因素。
Sci Rep. 2025 Mar 11;15(1):8394. doi: 10.1038/s41598-025-92618-0.
2
A Systematic Review of Microbiota in Cirrhosis: A Change Towards a More Pathogenic Predisposition.肝硬化中微生物群的系统评价:向更具致病性的易感性转变。
Int J Mol Sci. 2025 Jan 9;26(2):527. doi: 10.3390/ijms26020527.
3
Gut Microbiota and Cytokine Profile in Cirrhosis.

本文引用的文献

1
Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?肝硬化中的肠-肝轴:血流动力学变化是缺失的环节吗?
World J Clin Cases. 2021 Nov 6;9(31):9320-9332. doi: 10.12998/wjcc.v9.i31.9320.
2
Probiotics in hepatology: An update.肝病学中的益生菌:最新进展
World J Hepatol. 2021 Sep 27;13(9):1154-1166. doi: 10.4254/wjh.v13.i9.1154.
3
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update.EASL 临床实践指南:非侵入性检测评估肝脏疾病严重程度和预后——2021 更新版。
肝硬化中的肠道微生物群与细胞因子谱
J Clin Transl Hepatol. 2024 Aug 28;12(8):689-700. doi: 10.14218/JCTH.2024.00090. Epub 2024 Jun 28.
4
Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis.肝硬化中肠道微生物群和血管内皮功能障碍的生物标志物。
Int J Mol Sci. 2024 Feb 6;25(4):1988. doi: 10.3390/ijms25041988.
5
A retrospective cohort study of clinical characteristics and outcomes of type 2 diabetic patients with kidney disease.回顾性队列研究 2 型糖尿病肾病患者的临床特征和结局。
PeerJ. 2024 Feb 19;12:e16915. doi: 10.7717/peerj.16915. eCollection 2024.
J Hepatol. 2021 Sep;75(3):659-689. doi: 10.1016/j.jhep.2021.05.025. Epub 2021 Jun 21.
4
Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis.肠道菌群失调与肝硬化患者较差的长期预后相关。
World J Hepatol. 2021 May 27;13(5):557-570. doi: 10.4254/wjh.v13.i5.557.
5
Transjugular Liver Biopsy with Hemodynamic Evaluation: Correlation between Hepatic Venous Pressure Gradient and Histologic Diagnosis of Cirrhosis.经颈静脉肝活检及血流动力学评估:肝静脉压力梯度与肝硬化组织学诊断的相关性
J Clin Imaging Sci. 2021 Apr 26;11:25. doi: 10.25259/JCIS_233_2020. eCollection 2021.
6
Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma.肝硬化进展为肝细胞癌过程中肠道微生物群的改变
mSystems. 2020 Jun 16;5(3):e00153-20. doi: 10.1128/mSystems.00153-20.
7
Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.肝硬化导致肝癌患者肠道微生物群失调。
Cancer Med. 2020 Jun;9(12):4232-4250. doi: 10.1002/cam4.3045. Epub 2020 Apr 12.
8
Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease.与慢性乙型肝炎疾病进展相关的特征性肠道微生物群
Front Microbiol. 2020 Mar 20;11:383. doi: 10.3389/fmicb.2020.00383. eCollection 2020.
9
Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis?小肠细菌过度生长是肝硬化患者高动力循环的病因吗?
Turk J Gastroenterol. 2019 Nov;30(11):964-975. doi: 10.5152/tjg.2019.18551.
10
Gut-liver axis signaling in portal hypertension.门脉高压症中的肠道-肝脏轴信号。
World J Gastroenterol. 2019 Oct 21;25(39):5897-5917. doi: 10.3748/wjg.v25.i39.5897.